Allied Market Research recently published a report, titled, “DNA Vaccine Market by Product Type (Oncept, West Nile-Innovator, and Apex-IHN), Type (Therapeutic Vaccine, and Prophylactic Vaccines), and End User (Veterinary Clinics and Veterinary Hospitals): Global Opportunity Analysis and Industry Forecast, 2021–2030.” According to the analyst of AMR, the global DNA vaccine industry generated $422.77 million in 2020, and is projected to reach $774.43 million by 2030, witnessing a CAGR of 6.3% from 2021 to 2030.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/671
DNA Vaccine Market Overview:
Rise in prevalence of cancer and infectious diseases in humans and animals and surge in the number of antibiotic-resistant pathogens drive the growth of the global DNA vaccine market. However, lack of immunogenicity associated with DNA vaccines and limited knowledge about the effects of DNA vaccines on humans hinder the market growth. On the other hand, development of novel vaccines using DNA technology creates new opportunities in the coming years.
DNA Vaccine Market Segmentation:
The veterinary hospitals segment to continue its leadership status during the forecast period
Based on end user, the veterinary hospitals segment accounted for the largest share in 2020, holding nearly three-fourths of the global DNA vaccine market, and is expected to continue its leadership status during the forecast period. This is due to increase in incidences of animal diseases, rise in hospital admissions of animals for vaccine dose, and availability of trained veterinarians in the hospitals. However, the veterinary clinics segment is estimated to manifest the highest CAGR of 6.6% from 2021 to 2030, owing to rise in the number of veterinary clinics due to growth in ownership of companion animals as well as the availability of trained and licensed veterinarians in clinics.
The Oncept segment to continue its dominance during the forecast period
Based on product type, the Oncept segment contributed to the highest share in 2020, accounting for nearly half of the global DNA vaccine market, and is estimated to continue its dominance during the forecast period. This is due to rise in prevalence of canine melanoma cancer in animals, especially in dogs, which in turn, increased the demand for Oncept vaccine. However, the West Nile-Innovator segment is expected to witness the largest CAGR of 6.7% from 2021 to 2030.
The U.S. to continue its lead position in terms of revenue by 2030
Based on region, the U.S. held the highest market share in 2020, accounting for nearly 88% of the global DNA vaccine market, and is expected to continue its lead position in terms of revenue by 2030. This is due to presence of major key players, well-established healthcare infrastructure, high purchasing power, and higher healthcare expenditure levels. However, Canada is expected to portray the fastest CAGR of 7.1% during the forecast period, owing to product approvals in the country and presence of well-established healthcare infrastructure.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/671
DNA Vaccine Market: By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Important Questions Being Answered by the DNA Vaccine Market Report:
What is the DNA Vaccine market size and growth?
What are the prominent and latest trends impacting the market?
Which is the largest regional market for DNA Vaccine?
Key market players discussed in the DNA Vaccine Market report include Boehringer Ingelheim Gmbh (Merial), Eli-Lilly (Novartis Animal Health), Geneone Life Science, Geovax Labs, Inc., Inovio Pharmaceuticals (VGx Animal Health), Genexine, Inc, Viatris Inc. (Rottapharm Biotech), Takara Holdings (Takara Bio), Zoetis Inc. (Fort Dodge Animal Health), Zydus Cadila
Top Trending Report:-
Companion Diagnostic Market Size, Share & Growth Outlook 2022-2030
Regenerative Medicine Market Size, Share & Growth Outlook 2022-2030
Wearable Patch Market Size, Share & Growth Outlook 2022-2030
Dental Implants and Prosthetics Market Size, Share & Growth Outlook 2022-2030
IVF Devices and Consumables Market Size, Share & Growth Outlook 2022-2030
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest.”
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.